The future of blood-based biomarkers in liver cancer.
Blood tests combining multiple markers detect liver cancer earlier than AFP alone, especially helpful when ultrasound is unclear.
Multi-analyte blood-based biomarker panels combining AFP, AFP-L3, DCP, and ctDNA outperform AFP alone for HCC surveillance in at-risk populations; integration with imaging is essential for early-detection strategies in cirrhosis. This record was retained from the prior triage attempt for PubMed pipeline handoff.
What the study was
- Study design
- Narrative review
- Category
- Early Detection
- Maturity
- Exploratory
- Journal
- Journal of hepatology
Why it surfaced
High-impact Journal of Hepatology review by four leading HCC and liquid biopsy experts; directly addresses liquid biopsy and blood-based early detection for one of the most rapidly rising cancers; immediately relevant to Pulseomic surveillance pipeline.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.